Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-06-25 00:00:00 ET · period of report 2025-06-23 · accession 0000950170-25-089976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-25 | 2025-06-23+ | AKTX | Gaslightwala Abizer | Pres, CEO, Dir | P - Purchase | $1.16 | +6,146 | 272.4K | +2% | +$7,120 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2025-06-24 | P | A | 5,203 | $1.16 | 277,574 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F2) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. |
| 2 | Common | American Depositary Shares representing Ordinary Shares | 2025-06-23 | P | A | 943 | $1.15 | 272,371 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. |